The pathogenesis of community-acquired pneumonia

Research output: Contribution to journalArticle

Abstract

A number of studies have investigated the microbiological pathogenesis of community-acquired pneumonia (CAP) in patients admitted to hospital or, more specifically, to the intensive care unit. However, far fewer studies have sought to identify the cause of lower respiratory tract infections, including CAP, in the community, although what little is known about such mild infections suggests that their microbial aetiology is similar to that of infections in hospitalised patients. The wide variations between studies in the frequency of each microorganism can be explained by several factors, including differences in study populations (e.g. age, risk factors), geographical area, study sample, and microbiological methods. For example, some studies have focused on bacterial agents and others on viruses and intracellular bacteria. Extracellular bacteria, especially Streptococcus pneumoniae, are the most common, followed by Haemophilus influenzae, Staphylococcus aureus and, much less frequently, Gram-negative bacilli. Among atypicals and intracellular bacteria Mycoplasma pneumoniae is the most important, followed in frequency by Legionella sp. and Chlamydia sp. Viruses are involved in 5-20% of cases. Some 41 different prospective studies performed in Europe have established that ∼10 different microbial pathogens are the cause of the vast majority of cases of CAP, with occasional cases due to other rarer pathogens. The frequency of these organisms is similar in most European countries, although there is some geographic variation. Differences in frequency are also apparent according to the severity of illness. Nevertheless, it is generally recognised that S. pneumoniae is the most important causative bacterium in all countries. A relatively recent development among some of the common bacteria has been the appearance and spread of resistance to antibiotics to which they were once sensitive. However, the frequency of such resistance does vary markedly between European countries. Data from North American studies also suggest a major role for Streptococcus pneumoniae and atypicals. Also important are the clinical implications of co-infection on community acquired pneumonia management.

Original languageEnglish
Pages (from-to)80-84
Number of pages5
JournalEuropean Respiratory Review
Volume13
Issue number91
Publication statusPublished - Dec 2004

Fingerprint

Pneumonia
Bacteria
Streptococcus pneumoniae
Viruses
Legionella
Mycoplasma pneumoniae
Chlamydia
Age Factors
Haemophilus influenzae
Microbial Drug Resistance
Infection
Coinfection
Respiratory Tract Infections
Bacillus
Intensive Care Units
Staphylococcus aureus
Prospective Studies
Population

Keywords

  • Aetiology
  • Bacterial resistance
  • Community-acquired pneumonia
  • Diagnostic methods

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

The pathogenesis of community-acquired pneumonia. / Blasi, F.

In: European Respiratory Review, Vol. 13, No. 91, 12.2004, p. 80-84.

Research output: Contribution to journalArticle

@article{0162e6f33f14450093f2d0f4d7b47cdb,
title = "The pathogenesis of community-acquired pneumonia",
abstract = "A number of studies have investigated the microbiological pathogenesis of community-acquired pneumonia (CAP) in patients admitted to hospital or, more specifically, to the intensive care unit. However, far fewer studies have sought to identify the cause of lower respiratory tract infections, including CAP, in the community, although what little is known about such mild infections suggests that their microbial aetiology is similar to that of infections in hospitalised patients. The wide variations between studies in the frequency of each microorganism can be explained by several factors, including differences in study populations (e.g. age, risk factors), geographical area, study sample, and microbiological methods. For example, some studies have focused on bacterial agents and others on viruses and intracellular bacteria. Extracellular bacteria, especially Streptococcus pneumoniae, are the most common, followed by Haemophilus influenzae, Staphylococcus aureus and, much less frequently, Gram-negative bacilli. Among atypicals and intracellular bacteria Mycoplasma pneumoniae is the most important, followed in frequency by Legionella sp. and Chlamydia sp. Viruses are involved in 5-20{\%} of cases. Some 41 different prospective studies performed in Europe have established that ∼10 different microbial pathogens are the cause of the vast majority of cases of CAP, with occasional cases due to other rarer pathogens. The frequency of these organisms is similar in most European countries, although there is some geographic variation. Differences in frequency are also apparent according to the severity of illness. Nevertheless, it is generally recognised that S. pneumoniae is the most important causative bacterium in all countries. A relatively recent development among some of the common bacteria has been the appearance and spread of resistance to antibiotics to which they were once sensitive. However, the frequency of such resistance does vary markedly between European countries. Data from North American studies also suggest a major role for Streptococcus pneumoniae and atypicals. Also important are the clinical implications of co-infection on community acquired pneumonia management.",
keywords = "Aetiology, Bacterial resistance, Community-acquired pneumonia, Diagnostic methods",
author = "F. Blasi",
year = "2004",
month = "12",
language = "English",
volume = "13",
pages = "80--84",
journal = "European Respiratory Review",
issn = "0905-9180",
publisher = "European Respiratory Society",
number = "91",

}

TY - JOUR

T1 - The pathogenesis of community-acquired pneumonia

AU - Blasi, F.

PY - 2004/12

Y1 - 2004/12

N2 - A number of studies have investigated the microbiological pathogenesis of community-acquired pneumonia (CAP) in patients admitted to hospital or, more specifically, to the intensive care unit. However, far fewer studies have sought to identify the cause of lower respiratory tract infections, including CAP, in the community, although what little is known about such mild infections suggests that their microbial aetiology is similar to that of infections in hospitalised patients. The wide variations between studies in the frequency of each microorganism can be explained by several factors, including differences in study populations (e.g. age, risk factors), geographical area, study sample, and microbiological methods. For example, some studies have focused on bacterial agents and others on viruses and intracellular bacteria. Extracellular bacteria, especially Streptococcus pneumoniae, are the most common, followed by Haemophilus influenzae, Staphylococcus aureus and, much less frequently, Gram-negative bacilli. Among atypicals and intracellular bacteria Mycoplasma pneumoniae is the most important, followed in frequency by Legionella sp. and Chlamydia sp. Viruses are involved in 5-20% of cases. Some 41 different prospective studies performed in Europe have established that ∼10 different microbial pathogens are the cause of the vast majority of cases of CAP, with occasional cases due to other rarer pathogens. The frequency of these organisms is similar in most European countries, although there is some geographic variation. Differences in frequency are also apparent according to the severity of illness. Nevertheless, it is generally recognised that S. pneumoniae is the most important causative bacterium in all countries. A relatively recent development among some of the common bacteria has been the appearance and spread of resistance to antibiotics to which they were once sensitive. However, the frequency of such resistance does vary markedly between European countries. Data from North American studies also suggest a major role for Streptococcus pneumoniae and atypicals. Also important are the clinical implications of co-infection on community acquired pneumonia management.

AB - A number of studies have investigated the microbiological pathogenesis of community-acquired pneumonia (CAP) in patients admitted to hospital or, more specifically, to the intensive care unit. However, far fewer studies have sought to identify the cause of lower respiratory tract infections, including CAP, in the community, although what little is known about such mild infections suggests that their microbial aetiology is similar to that of infections in hospitalised patients. The wide variations between studies in the frequency of each microorganism can be explained by several factors, including differences in study populations (e.g. age, risk factors), geographical area, study sample, and microbiological methods. For example, some studies have focused on bacterial agents and others on viruses and intracellular bacteria. Extracellular bacteria, especially Streptococcus pneumoniae, are the most common, followed by Haemophilus influenzae, Staphylococcus aureus and, much less frequently, Gram-negative bacilli. Among atypicals and intracellular bacteria Mycoplasma pneumoniae is the most important, followed in frequency by Legionella sp. and Chlamydia sp. Viruses are involved in 5-20% of cases. Some 41 different prospective studies performed in Europe have established that ∼10 different microbial pathogens are the cause of the vast majority of cases of CAP, with occasional cases due to other rarer pathogens. The frequency of these organisms is similar in most European countries, although there is some geographic variation. Differences in frequency are also apparent according to the severity of illness. Nevertheless, it is generally recognised that S. pneumoniae is the most important causative bacterium in all countries. A relatively recent development among some of the common bacteria has been the appearance and spread of resistance to antibiotics to which they were once sensitive. However, the frequency of such resistance does vary markedly between European countries. Data from North American studies also suggest a major role for Streptococcus pneumoniae and atypicals. Also important are the clinical implications of co-infection on community acquired pneumonia management.

KW - Aetiology

KW - Bacterial resistance

KW - Community-acquired pneumonia

KW - Diagnostic methods

UR - http://www.scopus.com/inward/record.url?scp=9644270640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9644270640&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:9644270640

VL - 13

SP - 80

EP - 84

JO - European Respiratory Review

JF - European Respiratory Review

SN - 0905-9180

IS - 91

ER -